MetaCap

Arrowhead Pharmaceuticals Statistics

NASDAQ: ARWRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.37-2.28 (-5.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Arrowhead Pharmaceuticals by the numbers

Arrowhead Pharmaceuticals has a market capitalization of $5.85 billion based on 141.37M shares outstanding. With trailing EPS of $-5.11, Arrowhead Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.2% below its 50-day average and 41.3% below its 200-day average.

Average daily trading volume is 2.08M shares, or about $86.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ARWR valuation vs. peer median

ARWR compared with the median of 8 peer companies
MetricARWRPeer medianDifference
Market cap$5.85B$5.64B+4%
Avg. volume2.08M715.37K+191%

Peer median across 8 companies: SUPN, LGND, GRFS, MIRM, ABVX, BLTE, MANE, LQDA.

Valuation

Price / sales (latest FY)
12.97
EPS (TTM)
$-5.11

Price and trading

Previous close
43.65
Open
43.42
Day range
41.17 – 44.80
52-week range
40.43 – 95.49
52-week change
+2.27%
Beta
—
Volume
3.91M

Dividends and events

Annual dividend
None
Next earnings date
Nov 24, 2026

Additional statistics

Market Cap
5.85B
Forward Pe
-11.79
Eps
-5.11
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
95.49
Week52 Low
40.43
Avg Volume
2.08M
Shares Outstanding
141.37M
Ma50
59.24
Ma200
70.43
Earnings Date
Nov 24, 2026
Pct From52w High
-56.68%
Pct From52w Low
2.33%

Related